Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

Aurelie Guigon; Emmanuel Faure; Chloé Lemaire; Marie-Charlotte Chopin; Claire Tinez; Ady Assaf; Mouna Lazrek; Didier Hober; Laurence Bocket; Ilka Engelmann; Enagnon Kazali Alidjinou

doi:10.1016/j.jinf.2021.08.033

Retour

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

Article de revue

Avec comité de lecture

Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

Aurelie Guigon, Emmanuel Faure, Chloé Lemaire, Marie-Charlotte Chopin, Claire Tinez, Ady Assaf, Mouna Lazrek, Didier Hober, Laurence Bocket, Ilka Engelmann, …

The Journal of infection, Vol.84(2), pp.P248-288

Journal of Infection

01/02/2022

DOI: https://doi.org/10.1016/j.jinf.2021.08.033

PMID: 34437928

Résumé

Human health and pathology

Life Sciences

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance
Créateurs - sans rôle: Aurelie Guigon - Laboratoire de Virologie - ULR 3610
Emmanuel Faure - Inserm
Chloé Lemaire - Laboratoire de Virologie - ULR 3610
Marie-Charlotte Chopin - Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204
Claire Tinez - Virologie
Ady Assaf - Inserm
Mouna Lazrek - Virologie
Didier Hober - Virologie
Laurence Bocket - Virologie
Ilka Engelmann - Virologie
Enagnon Kazali Alidjinou - Virologie
Détails de publication: The Journal of infection, Vol.84(2), pp.P248-288
Publications en série: Journal of Infection
Éditeur: Elsevier
Identifiants: 99148021209311
Unité académique: Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
Langue: English
Type de ressource: Journal article